Vatalanib population pharmacokinetics in patients with myelodysplastic syndrome: CALGB 10105 (Alliance)-Reference-Cited by-同舟云学术

Vatalanib population pharmacokinetics in patients with myelodysplastic syndrome: CALGB 10105 (Alliance)

Published:2014-10-20 Issue:5 Volume:78 Page:1005-1013
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Wang Xiaofeng¹,Owzar Kouros²,Gupta Pankaj³,Larson Richard A.⁴,Mulkey Flora²,Miller Antonius A.⁵,Lewis Lionel D.⁶,Hurd David⁵,Vij Ravi⁷,Ratain Mark J.⁴,Murry Daryl J.¹^ORCID,

Affiliation:

1. University of Iowa; Iowa City IA USA

2. Alliance Statistics and Data Center; Duke University Medical Center; Durham NC USA

3. Minneapolis Veterans Administration Medical Center; University of Minnesota; Minneapolis MN USA

4. University of Chicago; Chicago IL USA

5. Wake Forest University School of Medicine; Winston Salem NC USA

6. The Norris Cotton Cancer Center and Geisel School of Medicine at Dartmouth; Lebanon NH USA

7. Washington University School of Medicine; St Louis MO USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12427/fullpdf

Reference33 articles.

1. Angiogenesis in myelodysplastic syndromes;Pruneri;Br J Cancer,1999

2. Angiogenesis in myelodysplastic syndromes;Deliliers;Leuk Res,1999

3. Molecular and biological properties of the vascular endothelial growth factor family of proteins;Ferrara;Endocr Rev,1992

4. Role of soluble mediators in angiogenesis;Bussolino;Eur J Cancer,1996

5. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia;Padró;Blood,2000

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Vitro Assessment of Inhibitory Effects of Kinase Inhibitors on CYP2C9, 3A and 1A2: Prediction of Drug-Drug Interaction Risk with Warfarin and Direct Oral Anticoagulants;European Journal of Pharmaceutical Sciences;2024-08

2. Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma;Journal of Experimental & Clinical Cancer Research;2023-04-03

3. Effects of multi-kinase inhibitors on the activity of cytochrome P450 2J2;Xenobiotica;2022-07-03

4. Multiparameter Evaluation of the Platelet-Inhibitory Effects of Tyrosine Kinase Inhibitors Used for Cancer Treatment;International Journal of Molecular Sciences;2021-10-18

5. In Vitro Screening of Six Protein Kinase Inhibitors for Time-Dependent Inhibition of CYP2C8 and CYP3A4: Possible Implications with regard to Drug-Drug Interactions;Basic & Clinical Pharmacology & Toxicology;2018-08-09